Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Group 1 Automotive
GPI
$3.13B
| $1.61M | ﹤0.01% |
24,876
+17,185
| +223% | +$1.04M |
|
|
SURF
2527
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $1.61M | ﹤0.01% |
336,819
-6,227
| -2% | -$30.6K |
|
2528
Bank of N.T. Butterfield & Son
NTB
$2.32B
| $1.61M | ﹤0.01% |
44,753
+25,072
| +127% | +$901K |
|
2529
National Presto Industries
NPK
$1.08B
| $1.6M | ﹤0.01% |
14,777
+10,137
| +218% | +$1.18M |
|
|
MEET
2530
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.6M | ﹤0.01% |
318,949
-481,612
| -60% | -$2.68M |
|
2531
Western Digital
WDC
$169B
| $1.6M | ﹤0.01% |
+44,047
| New | +$1.51M |
|
|
ICPT
2532
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.6M | ﹤0.01% |
14,307
+10,188
| +247% | +$1.11M |
|
2533
Orthofix Medical
OFIX
$397M
| $1.6M | ﹤0.01% |
28,333
-11,713
| -29% | -$657K |
|
2534
Sierra Bancorp
BSRR
$512M
| $1.6M | ﹤0.01% |
65,704
-3,095
| -4% | -$80.3K |
|
2535
Fabrinet
FN
$15.7B
| $1.6M | ﹤0.01% |
30,496
+22,430
| +278% | +$1.22M |
|
|
IRBT
2536
DELISTED
iRobot
IRBT
| $1.59M | ﹤0.01% |
13,551
+1,408
| +12% | +$150K |
|
2537
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $1.59M | ﹤0.01% |
43,489
+15,129
| +53% | +$544K |
|
|
AHT
2538
Ashford Hospitality Trust
AHT
$21.6M
| $1.59M | ﹤0.01% |
339
-562
| -62% | -$2.71M |
|
|
MDCO
2539
DELISTED
Medicines Co
MDCO
| $1.59M | ﹤0.01% |
56,824
-79,282
| -58% | -$1.87M |
|
|
EXK
2540
Endeavour Silver
EXK
$3.23B
| $1.58M | ﹤0.01% |
628,901
-290,760
| -32% | -$691K |
|
2541
Barings BDC
BBDC
$979M
| $1.58M | ﹤0.01% |
+161,013
| New | +$1.57M |
|
2542
Heron Therapeutics
HRTX
$59.3M
| $1.58M | ﹤0.01% |
+64,650
| New | +$1.69M |
|
2543
El Pollo Loco
LOCO
$476M
| $1.58M | ﹤0.01% |
121,307
-26,217
| -18% | -$395K |
|
2544
Huazhu Hotels Group
HTHT
$15.1B
| $1.57M | ﹤0.01% |
37,350
-28,216
| -43% | -$965K |
|
|
ABMD
2545
CALL
DELISTED
Abiomed Inc
ABMD
| $1.57M | ﹤0.01% |
5,500
+4,500
| +450% | +$1.5M |
|
2546
Federal Agricultural Mortgage
AGM
$2.37B
| $1.57M | ﹤0.01% |
21,615
+6,237
| +41% | +$455K |
|
2547
Hawaiian Electric Industries
HE
$1.98B
| $1.56M | ﹤0.01% |
+38,386
| New | +$1.46M |
|
|
MSC
2548
Studio City International Holdings
MSC
$341M
| $1.56M | ﹤0.01% |
98,525
-4,578
| -4% | -$73.4K |
|
2549
PUT
ResMed
RMD
$34B
| $1.56M | ﹤0.01% |
15,000
+5,000
| +50% | +$516K |
|
|
RFP
2550
DELISTED
Resolute Forest Products Inc.
RFP
| $1.56M | ﹤0.01% |
197,026
-288,002
| -59% | -$2.41M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.